TKNO vs. VERA, IOVA, PRAX, GLPG, WVE, APGE, EVO, IRON, ARQT, and AMPH
Should you be buying Alpha Teknova stock or one of its competitors? The main competitors of Alpha Teknova include Vera Therapeutics (VERA), Iovance Biotherapeutics (IOVA), Praxis Precision Medicines (PRAX), Galapagos (GLPG), Wave Life Sciences (WVE), Apogee Therapeutics (APGE), Evotec (EVO), Disc Medicine (IRON), Arcutis Biotherapeutics (ARQT), and Amphastar Pharmaceuticals (AMPH). These companies are all part of the "pharmaceutical products" industry.
Alpha Teknova vs.
Alpha Teknova (NASDAQ:TKNO) and Vera Therapeutics (NASDAQ:VERA) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, earnings, risk, valuation, profitability, community ranking, media sentiment and analyst recommendations.
Alpha Teknova currently has a consensus price target of $8.50, indicating a potential upside of 10.82%. Vera Therapeutics has a consensus price target of $65.44, indicating a potential upside of 124.39%. Given Vera Therapeutics' stronger consensus rating and higher probable upside, analysts clearly believe Vera Therapeutics is more favorable than Alpha Teknova.
Vera Therapeutics received 30 more outperform votes than Alpha Teknova when rated by MarketBeat users. Likewise, 65.00% of users gave Vera Therapeutics an outperform vote while only 39.13% of users gave Alpha Teknova an outperform vote.
In the previous week, Vera Therapeutics had 4 more articles in the media than Alpha Teknova. MarketBeat recorded 7 mentions for Vera Therapeutics and 3 mentions for Alpha Teknova. Alpha Teknova's average media sentiment score of 0.95 beat Vera Therapeutics' score of 0.16 indicating that Alpha Teknova is being referred to more favorably in the media.
Alpha Teknova has a beta of 0.34, indicating that its share price is 66% less volatile than the S&P 500. Comparatively, Vera Therapeutics has a beta of 1.11, indicating that its share price is 11% more volatile than the S&P 500.
Alpha Teknova has higher revenue and earnings than Vera Therapeutics. Vera Therapeutics is trading at a lower price-to-earnings ratio than Alpha Teknova, indicating that it is currently the more affordable of the two stocks.
Vera Therapeutics has a net margin of 0.00% compared to Alpha Teknova's net margin of -87.17%. Alpha Teknova's return on equity of -35.30% beat Vera Therapeutics' return on equity.
13.8% of Alpha Teknova shares are held by institutional investors. Comparatively, 99.2% of Vera Therapeutics shares are held by institutional investors. 15.2% of Alpha Teknova shares are held by insiders. Comparatively, 21.7% of Vera Therapeutics shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
Summary
Vera Therapeutics beats Alpha Teknova on 11 of the 18 factors compared between the two stocks.
Get Alpha Teknova News Delivered to You Automatically
Sign up to receive the latest news and ratings for TKNO and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Alpha Teknova Competitors List
Related Companies and Tools
This page (NASDAQ:TKNO) was last updated on 2/21/2025 by MarketBeat.com Staff
Free TKNO Stock Alerts